Posted by: Thixia | August 23, 2008

Investigational Oral Medication for RRMS

Trial Information

Summary: Investigational Oral Medication for RRMS

The goal of this study is to determine if an investigational oral medication is safe and effective. This treatment with the investigational oral medication is compared to treatment with a placebo. A placebo is an inactive substance or preparation used as a control in an experiment or test to determine the effectiveness of a medicinal drug. If you qualify, your participation may last up to two years and will require approximately 26 visits to the research office. Throughout that time, medical professionals with expertise in Multiple Sclerosis (MS) are available to monitor you closely.



If you are between the ages of 18 and 55, and have a confirmed diagnosis of Relapsing-Remitting Multiple Sclerosis (RRMS) with at least one relapse in the past 12 months, you may qualify for this study.



If you have never been treated with Copaxone (glatiramer acetate), you may also qualify for a related study, CONFIRM. CONFIRM is evaluating an oral treatment for RRMS.



If you would like more information on this study, or to Pre-Screen Yourself, visit


Contact Information:

Research Centers
Located in:
Dayton, OH

Bellevue, OH

Cleveland, OH




  1. Thanks for posting this information. I am new to your site and I will have to come back to read more. You have a lot here to read.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: